Find your next paid study

National Cancer Institute (NCI)NCT04671667

~$75 – $1,800

Actual pay is set by the research site.

Observational

Associations of Adverse Childhood Experiences, Sleep Disruption, and Vascular Dysfunction in Young Adults: The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies

The overall purpose of this study is to understand the role of disrupted sleep in the association of exposure to early life adversity (adverse childhood experi…

Adverse Childhood ExperiencesVascular DilatationSleep+6 more

Nathaniel JenkinsNCT06454344

~$10 – $1,125

Actual pay is set by the research site.

Phase 3

A Phase 3 Open-Label, Randomized Controlled Trial of T-bren (BL M07D1) vs. Platinum-based Chemotherapy in Patients With HER2 Expressing Metastatic Urothelial Cancer With Disease Progression on or After Anti-PD-(L)1-based Therapy

The objective of the study is to evaluate the efficacy and safety of T-bren in participants with HER2 expressing metastatic UC with progression on or after ant…

Urothelial CancerMetastatic Urothelial CancerBladder Cancer+9 more

~$50 – $2,100

Actual pay is set by the research site.

GliomaDiffuse Astrocytoma, IDH-Wildtype (Grade 2-4)Glioblastoma, IDH-wildtype+3 more

LU-TARGET: A Phase 1 Study of Lutetium-177-PSMA-617 Adjuvant Radiotherapy for IDH Wild Type Gliomas Expressing PSMA Following Standard Treatment

The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type…

Memorial Sloan Kettering Cancer CenterNCT07223034

Actual pay is set by the research site.

Observational

A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions

Family caregivers of people with dementia have to decide between tube feeding and hand feeding when persistent eating problems arise. This decision can be diff…

Dementia CaregiversEnd of Life Decision MakingAdvanced Dementia

Type and Grade of Toxicities, Demographic and Background CharacteristicsAdvanced, Metastatic, Recurrent Adenocarcinoma and Malignant Solid Neoplasm

~$10 – $1,125

Actual pay is set by the research site.

Yaolin PeiNCT07370311

Phase 2

Labyrinthin Vaccination for Patients With Lung Adenocarcinomas

This phase 2 trial tests the safety and effectiveness of a cancer vaccine called LabVax 3(22)-23 and GM-CSF in combination with pembrolizumab in treating adeno…

VA Office of Research and DevelopmentNCT07859592

~$75 – $1,800

Actual pay is set by the research site.

Locally Advanced Rectal CarcinomaRectal AdenocarcinomaStage II Rectal Cancer AJCC v8+7 more

Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX

This phase I trial investigates how well short-course radiation therapy followed by combination chemotherapy works in treating patients with stage II-III recta…

Jonsson Comprehensive Cancer CenterNCT04703101

Actual pay is set by the research site.

A Multicenter, Prospective, Open-Label Registry Study of the Utilization of EsoGuard, on Samples Collected Using EsoCheck, in an At-Risk Population Undergoing Standard of Care Screening for, and Management of, Previously Undiagnosed Barrett's Esophagus and/or Esophageal Adenocarcinoma

This is a multicenter, prospective, observational study designed to capture a limited set of data consisting of diagnostic test results and clinical management…

Barrett EsophagusEsophageal AdenocarcinomaBarretts Esophagus With Dysplasia+1 more

Lucid Diagnostics, Inc.NCT05965999

~$10 – $1,050

Actual pay is set by the research site.

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Background: People who have had an allogeneic hematopoietic stem cell transplant (HCT), cellular therapy (CT), or gene therapy (GT) have bone marrow or an imm…

Cellular Immunotherapy, AdoptiveGenetic TherapyTissue Donors+1 more

National Cancer Institute (NCI)NCT03000244

~$10 – $675

Actual pay is set by the research site.

Phase 2

Comprehensive Multimodal Prehabilitation Alone or in Combination With Planned Neoadjuvant Therapy in High-risk Patients Prior to Elective Major Cancer Surgery

In this 2-arm, non-randomized, phase II trial, the investigators will evaluate the efficacy and safety of comprehensive multimodal prehabilitation (CMMP) alone…

Hepatopancreaticobiliary (HPB) MalignancyOvarian Cancer (OvCa)Kidney Cancers+1 more

The Methodist Hospital Research InstituteNCT07050771

~$75 – $2,000

Actual pay is set by the research site.

Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8

Phase 1/2 Dose-Escalation and Cohort Study of STEAP1 CART With Enzalutamide in Participants With mCRPC

This phase I/II trial tests the safety and effectiveness of cell therapy (STEAP1 CART) with enzalutamide in treating patients with prostate cancer that continu…

Fred Hutchinson Cancer CenterNCT06236139

Actual pay is set by the research site.

Muscle Invasive Bladder CarcinomaStage III Bladder Cancer AJCC v8Stage IV Bladder Cancer AJCC v8

Consolidative Radiation Therapy or Cystectomy After Initial Favorable Response Succeeding Enfortumab Vedotin Plus Pembrolizumab (REINFORCE)--- A Pilot Feasibility Trial

This pilot feasibility clinical trial is evaluating a novel treatment strategy for patients with advanced bladder cancer that is unresectable, has spread to ne…